C-arms market seen reaching $3.24 billion by 2030

The global C-arms market rose to an estimated $2.55 billion in 2026 and is projected to reach $3.24 billion by 2030, according to The Business Research Company. Growth is being driven by more surgical procedures, wider use of image-guided surgery, and demand for portable imaging systems, with North America leading and Asia-Pacific expected to grow fastest.

Why it matters: - C-arms are a core imaging tool in surgery, orthopedics and emergency care, so rising demand points to broader use of image-guided procedures. - The market’s projected climb to $3.24 billion by 2030 signals continued spending on hospital imaging equipment and operating room technology. - Growth in chronic disease cases and an aging population is increasing the need for diagnostic and surgical imaging.

What happened: - The Business Research Company estimated the C-arms market at $2.55 billion in 2026, up from $2.39 billion in 2025. - The market is forecast to grow at a 6.2% CAGR and reach $3.24 billion by 2030. - North America held the largest share of the global market in 2025. - Asia-Pacific is projected to be the fastest-growing region over the forecast period.

The details: - C-arms get their name from their C-shaped design, which supports radiographic imaging during procedures. - The systems are used for fluoroscopic intraoperative imaging in emergency care, surgical interventions and orthopedic treatment. - Historical growth has been supported by more surgical procedures, stronger hospital infrastructure, wider use of fluoroscopic imaging in orthopedics, more mobile imaging systems and detector advances. - Future growth is expected to come from more image-guided surgeries, higher demand for compact and portable imaging devices, investment in digital operating rooms, more outpatient surgical centers and better imaging software. - Key trends expected in the market include AI-assisted imaging, greater use of mobile C-arms in operating rooms, wider deployment of flat panel detectors, more minimally invasive surgery and tighter radiation-dose optimization for patient safety. - The UK National Health Service reported in June 2024 that 3,615,330 people registered with general practitioners were diagnosed with non-diabetic hyperglycemia or pre-diabetes in 2023, up 18% from 3,065,825 in 2022. - The report covers North America, Asia-Pacific, South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - More information is available in the full report. - A free sample is available here.

Between the lines: - The market’s growth story is less about a single device category and more about the spread of imaging into more procedures and more care settings. - The fastest growth in Asia-Pacific suggests room for hospital buildouts and device adoption in markets still expanding their imaging capacity. - The emphasis on portable systems and radiation optimization points to buyer demand for flexibility and safer workflow, not just higher image quality.

What's next: - Vendors will likely compete on software, portability, detector performance and AI features as hospitals modernize operating rooms. - Outpatient surgery growth and broader adoption of minimally invasive procedures should continue to support demand. - Regional adoption patterns may shift further toward Asia-Pacific as healthcare investment rises.

The bottom line: - C-arms remain a steady-growth imaging category, with demand tied to surgical volume, chronic disease burden and the shift toward image-guided care.